LURALEM lurasidone hydrochloride 20 mg film-coated tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

lurasidone hydrochloride, Quantity: 20 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: hypromellose; maize starch; mannitol; croscarmellose sodium; magnesium stearate; titanium dioxide; macrogol 8000

Administration route:

Oral

Units in package:

30 Tablets, 28 tablets

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

LURALEM is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

Product summary:

Visual Identification: White to off white round shaped biconvex film-coated tablets debossed with 515 on one side and L on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

2020-06-24